Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
AP
Apyx Medical Corporation Common Stock
APYX
Volume
52.40K
Next Earnings
November 5th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
AP
APYX
AP
Apyx Medical Corporation Common Stock
APYX
News
·
New Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion®
Mkt Cap
$107.8M
Volume
52.40K
Next Earnings
November 5th
Chart
Financials
Earnings
News
About
Insider
Filings
New Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion®
Apyx Medical announced publication of clinical data demonstrating that a combination treatment approach using Avéli® for subcision and Renuvion® for plasma radiofrequency energy shows significant improvement in cellulite and skin laxity. In a study of 22 patients, 81.8% showed improvement in cellulite appearance at 180 days post-treatment, with objective imaging confirming measurable reductions in dimple volume and histological evidence of increased collagen and elastin.
GlobeNewswire Inc. · May 21, 2026
Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™
Apyx Medical received FDA 510(k) clearance to add power liposuction capability to its AYON Body Contouring System, an advanced liposuction modality using reciprocating cannulas to improve surgical efficiency. The company plans a limited commercial launch to work with early adopters before broader scaling. This expansion positions AYON as a comprehensive all-in-one platform combining fat removal, tissue contouring, and electrosurgical capabilities.
GlobeNewswire Inc. · May 11, 2026
Apyx Medical Corporation Announces Pricing of $10 Million Public Offering of Common Stock
Apyx Medical Corporation has priced a public offering of 2,762,431 shares of common stock at $3.62 per share, expecting to raise approximately $10 million for working capital and general corporate purposes.
Benzinga · Nov 18, 2025
Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System™
Apyx Medical Corporation received FDA clearance for its AYON Body Contouring System, which combines multiple technologies for body contouring procedures. The company plans to launch the system with key surgeons in the second half of 2025.
GlobeNewswire Inc. · May 13, 2025
Apyx Medical Corporation Submits 510(k) Premarket Notification to the U.S. Food and Drug Administration for the AYON Body Contouring System™
Apyx Medical Corporation has submitted a 510(k) premarket notification to the FDA for its AYON Body Contouring System, which is designed to provide comprehensive body contouring solutions through an all-in-one platform.
GlobeNewswire Inc. · Jan 6, 2025
Butterfly Network's Stock Surges on iQ3 Device Launch in Europe
Butterfly Network's stock surged 26.9% after the company announced the commercial launch of its third-generation handheld point-of-care ultrasound system, Butterfly iQ3, in Europe. The device's strong uptake in the U.S. market and its advanced features are driving investor optimism.
Benzinga · Sep 5, 2024
Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates
Apyx (APYX) delivered earnings and revenue surprises of -22.22% and 6.27%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research · May 9, 2024
Crude Oil Moves Lower; Accenture Shares Tumble After Q2 Results
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 300 points on Thursday. The Dow traded up 0.77% to 39,814.95 while the NASDAQ rose 0.25% to 16,410.54. The S&P 500 also rose, gaining, 0.38% to 5,244.72. Check This Out: Micron, Accenture And 3 Stocks To Watch Heading Into Thursday Leading and Lagging Sectors Industrials shares jumped by 1% on Thursday. In trading on Thursday, materials shares rose by just 0.1%. Top Headline Shares of Accenture Plc (NYSE: ACN) dipped around 9% on Thursday after the company reported results for its fiscal second quarter. Accenture reported second-quarter fiscal 2024 sales of $15.80 billion compared with the consensus of $15.84 billion, flat Y/Y in U.S. dollars and local currency. Revenues were slightly above the midpoint of the company’s guided range of $15.40 billion – $16.00 billion. Adjusted EPS of $2.77 beat the consensus of $2.66. Accenture expects fiscal 2024 adjusted EPS of $11.97 – $12.20 (prior $11.97 – $12.32) versus consensus of $12.24. For fiscal 2024, the company expects revenue growth of 1% – 3% (prior 2% – 5%) in local currency vs. $66.18 billion consensus. Equities Trading UP Yield10 Bioscience, Inc. (NASDAQ: YTEN) shares shot up 70% to $0.4124 after the company announced that the USDA-APHIS Biotechnology Regulatory Services determined that the Camelina sativa varieties may be planted and bred in the United States. Shares of CuriosityStream Inc. (NASDAQ: CURI) got a boost, surging 56% to $0.91 ...
Benzinga · Mar 21, 2024
Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-than-expected second-quarter revenue and issued FY24 guidance. FactSet Research posted adjusted earnings of $4.22 per share, beating market estimates of $3.88 per share. The company’s quarterly sales came in at $545.95 million, missing expectations of $546.80 million, according to data from Benzinga Pro. FactSet Research shares dipped 5.2% to $462.36 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Yield10 Bioscience, Inc. (NASDAQ: YTEN) shares jumped 136.7% to $0.5751 after the company announced that the USDA-APHIS Biotechnology Regulatory Services determined that the Camelina sativa varieties may be planted and bred in the United States. Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) shares jumped 101.7% to $2.6850 after falling 11% on Wednesday. CuriosityStream Inc. (NASDAQ: CURI) rose 63.2% to $2.6850 after the company reported financial results for fourth quarter. Portage Biotech Inc. (NASDAQ: PRTG) gained 53.7% to $0.7525. Lufax Holding Ltd (NYSE: LU) climbed 41.3% to $4.76 following fourth-quarter results. Asset Entities Inc. (NASDAQ: ASST) shares climbed 37% to $0.7173 after the company announced that it entered into an agreement with Zendrop. Cazoo Group Ltd (NYSE: CZOO) gained 33% to $4.6475. Guess?, Inc. (NYSE: GES) shares rose 23.1% to $31.95 as the company reported better-than-expected fourth-quarter financial results and declared a special dividend of $2.25 per share. Nortech Systems Incorporated (NASDAQ: NSYS) surged 22.3% to $13.35 after the company reported fourth-quarter results. JOANN Inc. (NASDAQ: JOAN) gained 20.8% to $0.1631. Aemetis, Inc. (NASDAQ: AMTX) climbed 18.4% to $4.3238 after the company announced approval by the U.S. Citizenship and Immigration Services for a $200 million of EB-5 program investment for the Riverbank sustainable aviation fuel, production plant, the dairy renewable natural gas project, the ...
Benzinga · Mar 21, 2024
Gold Gains 1%; Micron Posts Upbeat Results
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up 0.84% to 39,844.27 while the NASDAQ rose 0.61% to 16,469.28. The S&P 500 also rose, gaining, 0.56% to 5,254.11. Check This Out: Micron, Accenture And 3 Stocks To Watch Heading Into Thursday Leading and Lagging Sectors Industrials shares jumped by 1% on Thursday. In trading on Thursday, materials shares rose by just 0.1%. Top Headline Micron Technology, Inc. (NASDAQ: MU) reported upbeat results for its second quarter and issued strong third-quarter guidance on Wednesday. Micron reported first-quarter revenue of $5.82 billion, which beat the consensus estimate of $5.342 billion. The company reported adjusted earnings of 42 cents per share, which easily beat analyst estimates for a loss of 25 cents per share, according to data from Benzinga Pro. Equities Trading UP Yield10 Bioscience, Inc. (NASDAQ: YTEN) shares shot up 108% to $0.5046 after the company announced that the USDA-APHIS Biotechnology Regulatory Services determined that the Camelina sativa varieties may be planted and bred in the United States. Shares of CuriosityStream Inc. (NASDAQ: CURI) got a boost, surging 55% to $0.90 after the company reported financial results for fourth quarter. Lufax Holding Ltd (NYSE: LU) shares were also up, gaining 40% to $4.7306 following fourth-quarter results. Equities Trading DOWN Movella Holdings Inc. (NASDAQ: MVLA) shares ...
Benzinga · Mar 21, 2024
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
AP
APYX
Apyx Medical Corporation Common Stock
Buy
Sell
Market
Limit
Soon
APYX
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any APYX yet.
Related Tickers
Earnings